Literature DB >> 18599592

Endothelial dysfunction and vascular inflammation in type 2 diabetes: interaction of AGE/RAGE and TNF-alpha signaling.

Anna Csiszar, Zoltan Ungvari.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18599592      PMCID: PMC2519200          DOI: 10.1152/ajpheart.00644.2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


× No keyword cloud information.
  24 in total

1.  An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness.

Authors:  M Asif; J Egan; S Vasan; G N Jyothirmayi; M R Masurekar; S Lopez; C Williams; R L Torres; D Wagle; P Ulrich; A Cerami; M Brines; T J Regan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

2.  Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses.

Authors:  Giuseppina Basta; Guido Lazzerini; Marika Massaro; Tommaso Simoncini; Piero Tanganelli; Caifeng Fu; Thomas Kislinger; David M Stern; Ann Marie Schmidt; Raffaele De Caterina
Journal:  Circulation       Date:  2002-02-19       Impact factor: 29.690

3.  Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function.

Authors:  Anna Csiszar; Zoltan Ungvari; John G Edwards; Pawel Kaminski; Michael S Wolin; Akos Koller; Gabor Kaley
Journal:  Circ Res       Date:  2002-06-14       Impact factor: 17.367

4.  Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine.

Authors:  D Edelstein; M Brownlee
Journal:  Diabetes       Date:  1992-01       Impact factor: 9.461

5.  Aging-induced proinflammatory shift in cytokine expression profile in coronary arteries.

Authors:  Anna Csiszar; Zoltan Ungvari; Akos Koller; John G Edwards; Gabor Kaley
Journal:  FASEB J       Date:  2003-04-22       Impact factor: 5.191

6.  Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice.

Authors:  M T Goova; J Li; T Kislinger; W Qu; Y Lu; L G Bucciarelli; S Nowygrod; B M Wolf; X Caliste; S F Yan; D M Stern; A M Schmidt
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

7.  Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of tumor necrosis factor-alpha, NAD(P)H oxidase, and inducible nitric oxide synthase.

Authors:  Zoltan Ungvari; Anna Csiszar; John G Edwards; Pawel M Kaminski; Michael S Wolin; Gabor Kaley; Akos Koller
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-02-13       Impact factor: 8.311

8.  AGE/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice.

Authors:  Xue Gao; Hanrui Zhang; Ann Marie Schmidt; Cuihua Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-06       Impact factor: 4.733

9.  Proinflammatory phenotype of coronary arteries promotes endothelial apoptosis in aging.

Authors:  Anna Csiszar; Zoltan Ungvari; Akos Koller; John G Edwards; Gabor Kaley
Journal:  Physiol Genomics       Date:  2004-03-12       Impact factor: 3.107

10.  Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties.

Authors:  C Esposito; H Gerlach; J Brett; D Stern; H Vlassara
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

View more
  8 in total

1.  Ly6C+ Inflammatory Monocyte Differentiation Partially Mediates Hyperhomocysteinemia-Induced Vascular Dysfunction in Type 2 Diabetic db/db Mice.

Authors:  Pu Fang 方璞; Xinyuan Li 李欣源; Huimin Shan 单慧敏; Jason J Saredy; Ramon Cueto; Jixiang Xia 夏继祥; Xiaohua Jiang 蒋晓华; Xiao-Feng Yang 杨晓峰; Hong Wang 王虹
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-01       Impact factor: 8.311

2.  Toxicity features of high glucose on endothelial cell cycle and protection by Dan Gua-Fang in ECV-304 in high glucose medium.

Authors:  Xian-Pei Heng; Ke-Ji Chen; Zhen-Feng Hong; Wei-Dong He; Ke-Dan Chu; Jiu-Mao Lin; Hai-Xia Zheng; Liu-Qing Yang; Su-Ping Huang; Yuan-Long Lan; Ling Chen; Fang Guo
Journal:  Chin J Integr Med       Date:  2012-02-09       Impact factor: 1.978

3.  Molecular Mechanism of the Effect of Huanglian Jiedu Decoction on Type 2 Diabetes Mellitus Based on Network Pharmacology and Molecular Docking.

Authors:  Bei Yin; Yi-Ming Bi; Guan-Jie Fan; Ya-Qing Xia
Journal:  J Diabetes Res       Date:  2020-10-19       Impact factor: 4.011

4.  Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products.

Authors:  Chun Liang; Yusheng Ren; Hongbin Tan; Zhiqing He; Qijun Jiang; Jianxiang Wu; Yi Zhen; Min Fan; Zonggui Wu
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

5.  Role of peroxisome proliferators-activated receptor-gamma in advanced glycation end product-mediated functional loss of voltage-gated potassium channel in rat coronary arteries.

Authors:  Side Gao; Bing Hua; Qingbo Liu; Huirong Liu; Weiping Li; Hongwei Li
Journal:  BMC Cardiovasc Disord       Date:  2020-07-14       Impact factor: 2.298

Review 6.  Biomarkers of Oxidative Stress in Metabolic Syndrome and Associated Diseases.

Authors:  Rosa Vona; Lucrezia Gambardella; Camilla Cittadini; Elisabetta Straface; Donatella Pietraforte
Journal:  Oxid Med Cell Longev       Date:  2019-05-05       Impact factor: 6.543

7.  A Network Pharmacology-Based Strategy For Predicting Active Ingredients And Potential Targets Of LiuWei DiHuang Pill In Treating Type 2 Diabetes Mellitus.

Authors:  Shui-Han Zhang; Yu-Hui Qin; Dan He; Jian-Hua Huang; Zhe-Yu Zhang; Qing Du; Wei-Jun Peng; Rong Yu; Si-Fang Zhang
Journal:  Drug Des Devel Ther       Date:  2019-11-28       Impact factor: 4.162

8.  Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.

Authors:  Ryoichi Arita; Yasuaki Hata; Shintaro Nakao; Takeshi Kita; Muneki Miura; Shuhei Kawahara; Souska Zandi; Lama Almulki; Faryan Tayyari; Hiroaki Shimokawa; Ali Hafezi-Moghadam; Tatsuro Ishibashi
Journal:  Diabetes       Date:  2008-10-07       Impact factor: 9.461

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.